Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam H Balen

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Human Reproduction (Oxford, England)|January 13, 2023
Association between body mass index, weight loss and the chance of pregnancy in women with polycystic ovary syndrome and overweight or obesity: a retrospective cohort study in the UKChristiane Lundegaard Haase, Anette Varbo, Peter Nørkjær Laursen, et al.
Fertility and Sterility|October 3, 2006
Elective cryopreservation of embryos at the pronucleate stage in women at risk of ovarian hyperstimulation syndrome may affect the overall pregnancy rateSrinivasan Vyjayanthi, Tommy Tang, Azza Fattah, et al.
The Cochrane Database of Systematic Reviews|July 10, 2009
WITHDRAWN: Insulin-sensitising drugs for polycystic ovary syndromeThomas Tang, Jonathan M Lord, Robert J Norman, et al.
The Cochrane Database of Systematic Reviews|October 13, 2009
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityThomas Tang, Jonathan M Lord, Robert J Norman, et al.
The Cochrane Database of Systematic Reviews|January 22, 2010
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityThomas Tang, Jonathan M Lord, Robert J Norman, et al.
The Cochrane Database of Systematic Reviews|November 29, 2017
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityLara C Morley, Thomas Tang, Ephia Yasmin, et al.
Human Fertility (Cambridge, England)|December 23, 2014
British Fertility Society Policy and Practice Committee: adjuvants in IVF: evidence for good clinical practiceLuciano G Nardo, Tarek El-Toukhy, Jane Stewart, et al.
Human Reproduction (Oxford, England)|July 28, 2010
Metabolism and karyotype analysis of oocytes from patients with polycystic ovary syndromeSarah E Harris, Deivanayagam Maruthini, Thomas Tang, et al.
Human Reproduction Update|July 12, 2014
Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indicationsVanitha N Sivalingam, Jenny Myers, Susie Nicholas, et al.
Human Reproduction (Oxford, England)|July 6, 2025
Association between weight loss and reproductive outcomes among women with overweight or obesity: a cohort study using UK real-world dataMaximiliane Lara Verfürden, Volker Schnecke, Eva Winning Lehmann, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Human Reproduction (Oxford, England)|January 13, 2023
Association between body mass index, weight loss and the chance of pregnancy in women with polycystic ovary syndrome and overweight or obesity: a retrospective cohort study in the UKChristiane Lundegaard Haase, Anette Varbo, Peter Nørkjær Laursen, et al.
Fertility and Sterility|October 3, 2006
Elective cryopreservation of embryos at the pronucleate stage in women at risk of ovarian hyperstimulation syndrome may affect the overall pregnancy rateSrinivasan Vyjayanthi, Tommy Tang, Azza Fattah, et al.
The Cochrane Database of Systematic Reviews|July 10, 2009
WITHDRAWN: Insulin-sensitising drugs for polycystic ovary syndromeThomas Tang, Jonathan M Lord, Robert J Norman, et al.
The Cochrane Database of Systematic Reviews|October 13, 2009
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityThomas Tang, Jonathan M Lord, Robert J Norman, et al.
The Cochrane Database of Systematic Reviews|January 22, 2010
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityThomas Tang, Jonathan M Lord, Robert J Norman, et al.
The Cochrane Database of Systematic Reviews|November 29, 2017
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityLara C Morley, Thomas Tang, Ephia Yasmin, et al.
Human Fertility (Cambridge, England)|December 23, 2014
British Fertility Society Policy and Practice Committee: adjuvants in IVF: evidence for good clinical practiceLuciano G Nardo, Tarek El-Toukhy, Jane Stewart, et al.
Human Reproduction (Oxford, England)|July 28, 2010
Metabolism and karyotype analysis of oocytes from patients with polycystic ovary syndromeSarah E Harris, Deivanayagam Maruthini, Thomas Tang, et al.
Human Reproduction Update|July 12, 2014
Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indicationsVanitha N Sivalingam, Jenny Myers, Susie Nicholas, et al.
Human Reproduction (Oxford, England)|July 6, 2025
Association between weight loss and reproductive outcomes among women with overweight or obesity: a cohort study using UK real-world dataMaximiliane Lara Verfürden, Volker Schnecke, Eva Winning Lehmann, et al.
Pageof 8